Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Stock-Based Compensation Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Stock-Based Compensation
$64.2m
CAGR 3-Years
97%
CAGR 5-Years
154%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abcellera Biologics Inc's Stock-Based Compensation?
Stock-Based Compensation
64.2m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Stock-Based Compensation amounts to 64.2m USD.

What is Abcellera Biologics Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
154%

Over the last year, the Stock-Based Compensation growth was 30%. The average annual Stock-Based Compensation growth rates for Abcellera Biologics Inc have been 97% over the past three years , 154% over the past five years .

Back to Top